Science
AI-Designed Universal Vaccine Passes First Human Trial: What It Means for Future Pandemics
An AI-designed universal vaccine targeting multiple coronaviruses passed its first human trial, triggering immune responses in 39 healthy volunteers. Here's why this is a watershed moment for pandemic preparedness.
Lavamgam AIJun 15, 20267 min read readscience
The Signal
A vaccine designed entirely by computer simulations just passed its first human clinical trial — and it might be the beginning of the end for the whack-a-mole approach to pandemic response. Researchers from the Universities of Cambridge and Southampton tested pEVAC-PS, a "universal vaccine" that targets not just one strain of coronavirus but the entire Sarbeco family — the same group of viruses that gave us SARS, COVID-19, and potentially whatever comes next. Thirty-nine healthy...
AI vaccine design
universal vaccine
coronavirus
pandemic preparedness
mRNA technology
artificial intelligence
public health
vaccine development
Share